
1. case rep oncol med. 2018 oct 17;2018:5985131. doi: 10.1155/2018/5985131.
ecollection 2018.

a rare case pembrolizumab-induced reactivation hepatitis b.

pandey a(1), ezemenari s(1), liaukovich m(1), richard i(1), boris a(1).

author information: 
(1)department hematology oncology, brookdale university hospital, medical 
center, brooklyn, usa.

hepatitis b virus (hbv) infection common across world, especially asia,
africa, southern europe, latin america. association hbv infection in
patients suffering different oncological conditions well established.
many cases hbv reactivation reported patients on
immunosuppressive chemotherapy patients undergoing hematopoietic bone
marrow transplantations. one case reported far hbv
reactivation patient treated programmed cell death receptor 1 (pd-1)
checkpoint inhibitors setting hiv status. report case a
51-year-old male, former smoker, diagnosed stage iv poorly differentiated
adenocarcinoma lung, started pembrolizumab, developed
reactivation chronic hepatitis requiring antiviral therapy.

doi: 10.1155/2018/5985131 
pmcid: pmc6207901
pmid: 30416833 

